DynamX® Bioadaptor Therapy | Next-Generation Coronary Artery Treatment | MediHeart Medical Center Güzelyurt
DynamX® Bioadaptor is one of the next-generation interventional cardiology technologies aiming to support vascular motion in coronary artery disease. Get information about DynamX® Bioadaptor application evaluations by Prof. Dr. Osman Beton and the treatment process.
DynamX® Bioadaptor
Coronary artery disease is one of the important cardiovascular diseases that cause a decrease in blood flow reaching the heart muscle as a result of narrowing or blockage of the vessels supplying the heart. Today, thanks to technological developments in interventional cardiology, next-generation treatment approaches aiming not only to open the vessel but also to preserve the natural movement characteristics of the vessel as much as possible are being developed. DynamX® Bioadaptor is one of the innovative systems that can be used in suitable patients and draws attention with its bioadaptive structure in coronary artery treatment.
While standard stent technologies support the vessel within a rigid structure, DynamX® Bioadaptor offers a specialized bioadaptive platform aiming to support the physiological movements of the vessel through a different design approach. This technology may not be suitable for every patient. The treatment decision is made by evaluating the vascular structure, location of the narrowing, lesion characteristics, and the overall cardiovascular status of the patient together.
At MediHeart Medical Center Güzelyurt Cardiology Department, interventional cardiology procedures are planned by our Cardiology Specialist Prof. Dr. Osman Beton in accordance with current international treatment approaches. Whether the patient is suitable for DynamX® Bioadaptor usage is decided after a detailed examination, coronary angiography findings, and necessary diagnostic tests.
What is DynamX® Bioadaptor?
DynamX® Bioadaptor is one of the bioadaptive implant technologies used in coronary vessel treatment. While aiming to restore blood flow in the vessel, the system also features a different design approach directed at supporting the natural biomechanical movements of the vessel.
Coronary arteries are dynamic structures capable of expanding and contracting during each heartbeat. Therefore, some interventional treatment technologies developed today target not only maintaining vessel openness but also preserving the natural physiological characteristics of the vessel as much as possible. DynamX® Bioadaptor is one of the innovative systems developed in line with this approach.
Who May Be Suitable for DynamX® Bioadaptor?
The same treatment method is not preferred for every coronary artery narrowing. Patient age, accompanying diseases, vessel diameter, length of the narrowing, vascular structure, and interventional evaluation results are decisive factors in treatment selection.
DynamX® Bioadaptor can be considered for evaluation in the following patient groups:
Suitable patients with coronary artery disease
Coronary artery narrowings where interventional treatment is planned
Patients whose vascular structure is deemed suitable for bioadaptive implant usage
Individuals predicted to benefit from this technology following a cardiology evaluation
The definitive treatment plan is established solely after the clinical evaluation by the cardiology specialist.
How is DynamX® Bioadaptor Applied?
The procedure is applied similarly to interventional cardiology procedures performed during coronary angiography. Heart vessels are usually reached using thin catheters through the wrist (radial artery) or groin vessel.
After the narrowing in the coronary artery is evaluated in detail, DynamX® Bioadaptor is placed in a controlled manner in patients deemed suitable. When necessary, intravascular imaging methods can also be utilized during the procedure. Thus, correct positioning of the implant and detailed evaluation of the vascular structure are aimed.
The procedure duration can vary depending on the vascular structure, lesion characteristics, and the interventional method to be applied. Following the procedure, the patient is kept under observation for a specific period and the discharge plan is made according to the general health status.
Potential Advantages of DynamX® Bioadaptor Technology
The main objective of new technologies in interventional cardiology is not only to provide vessel openness but also to support long-term vascular functions. DynamX® Bioadaptor is evaluated as one of the bioadaptive systems developed in line with this objective.
In suitable patients, it can be used for goals such as:
Supporting the coronary vessel,
Restoring blood flow,
Supporting the natural movement characteristics of the vessel,
Enabling personalized planning of interventional treatment.
However, obtaining the same clinical outcomes in every patient cannot be guaranteed. Treatment success depends on many factors such as the patient’s vascular structure, risk factors, medications used, and regular cardiology checkups.
Are There Risks of DynamX® Bioadaptor Treatment?
As with any interventional cardiology procedure, the application of DynamX® Bioadaptor carries certain risks. The level of risk can vary according to the patient’s age, accompanying diseases, vascular structure, lesion characteristics, and the scope of the intervention to be applied.
Before the procedure, the patient’s medical history is evaluated in detail, medications used are reviewed, and necessary laboratory and imaging examinations are completed. The aim is to determine the most appropriate approach for the patient by evaluating the potential benefits that the treatment can provide alongside procedural risks in a balanced manner. Therefore, DynamX® Bioadaptor application must be planned and performed by experienced interventional cardiology teams.
Post-Procedure Recovery Process
Patients are kept under observation for a specific period after DynamX® Bioadaptor application. The discharge time can vary depending on the scope of the intervention applied, the access site used, and the general health status of the patient. Patients deemed suitable can return to daily life in a controlled manner within a short time.
Adhering to physician recommendations during the recovery period carries great importance for successful long-term outcomes. Regular medication usage, not missing follow-up appointments, smoking cessation, keeping blood pressure and diabetes under control, monitoring cholesterol levels, and adopting heart-healthy eating habits are critical components of the treatment.
Why is Patient Evaluation Important in DynamX® Bioadaptor Treatment?
Interventional treatment to be applied in coronary artery disease is not identical for all patients. Many factors such as vessel diameter, length of narrowing, calcification level, vascular bifurcation regions, and overall cardiac function influence treatment selection.
For this reason, a detailed cardiology evaluation is performed before deciding on the use of DynamX® Bioadaptor. When necessary, coronary angiography images are examined in detail, and the vascular structure is analyzed using intravascular imaging methods. Thus, the objective is to create the most suitable interventional treatment plan for every patient.
DynamX® Bioadaptor Approach at MediHeart Medical Center Güzelyurt
At MediHeart Medical Center Güzelyurt Cardiology Department, current interventional cardiology applications are utilized in the diagnosis and treatment of coronary artery disease. The treatment process is addressed with a holistic approach encompassing not only the procedural stage, but also the patient’s initial evaluation, risk analysis, treatment planning, and post-procedure follow-up.
Our Cardiology Specialist Prof. Dr. Osman Beton creates a personalized treatment plan by evaluating each patient’s clinical findings, imaging results, and current international scientific guidelines together. Whether DynamX® Bioadaptor technology is suitable is decided as a result of this comprehensive evaluation.
Frequently Asked Questions
Is DynamX® Bioadaptor a classic stent?
No. DynamX® Bioadaptor is one of the next-generation coronary implant technologies developed with a bioadaptive design approach. It possesses different structural characteristics compared to standard stents.
Can DynamX® Bioadaptor be used in every vessel narrowing?
No. Not every coronary artery narrowing may be suitable for this technology. The decision is made by evaluating the vascular structure, lesion characteristics, and general health status of the patient.
Is DynamX® Bioadaptor application a surgery?
No. It is not open-heart surgery. Within the scope of interventional cardiology, it is a minimally invasive procedure mostly performed via catheter access through the wrist or groin vessel.
Is pain felt during the procedure?
The procedure is performed under local anesthesia. A large majority of patients do not feel significant pain during the procedure. When necessary, patient comfort is supported with additional medication applications.
Is it necessary to use medication after the procedure?
Yes. Medications to be used after a coronary intervention are planned specifically for the patient. The duration and dosage of medications should be regulated only according to the recommendation of the cardiology specialist.
Is DynamX® Bioadaptor permanent?
DynamX® Bioadaptor is one of the implant technologies developed to support the coronary vessel. Detailed information about its structural properties and working principles is shared by the cardiology specialist according to the clinical condition of the patient.
Conclusion
DynamX® Bioadaptor takes its place among bioadaptive technologies used in the interventional treatment of coronary artery disease, offering a different approach aimed at supporting the vessel and preserving physiological movement characteristics in suitable patients. However, this technology is not suitable for every patient, and the treatment decision must be made following a detailed cardiological evaluation.
At MediHeart Medical Center Güzelyurt Cardiology Department, the most appropriate interventional treatment plan is created for each patient in line with comprehensive evaluations performed by Prof. Dr. Osman Beton. Patients applying from across Güzelyurt, TRNC, Cyprus, and North Cyprus can receive detailed evaluations regarding coronary artery diseases, interventional cardiology applications, and next-generation treatment options. If you have complaints such as chest pain, shortness of breath, decreased exercise capacity, or symptoms that may indicate coronary artery disease, early cardiology evaluation can contribute to the timely planning of potential treatment options.